benzoxazoles has been researched along with Renal Insufficiency in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chihara, A; Nakamura, T; Node, K; Sato, E; Tanaka, A | 1 |
| Ikeda, U; Joko, K; Kasai, T; Komatsu, T; Miura, T; Mochidome, T; Sunohara, D | 1 |
| Arai, H; Araki, E; Ishibashi, S; Of The K-Study Group, OB; Suganami, H; Yamashita, S; Yokote, K | 1 |
1 trial(s) available for benzoxazoles and Renal Insufficiency
| Article | Year |
|---|---|
Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment.
Topics: Aged; Benzoxazoles; Biomarkers; Butyrates; Dyslipidemias; Female; Humans; Kidney Function Tests; Lipids; Male; Middle Aged; PPAR alpha; Renal Insufficiency; Treatment Outcome | 2019 |
2 other study(ies) available for benzoxazoles and Renal Insufficiency
| Article | Year |
|---|---|
Effect of pemafibrate, a novel selective peroxisome proliferator-activated receptor-alpha modulator (SPPARMα), on urinary protein excretion in IgA nephropathy with hypertriglyceridemia.
Topics: Adult; Atherosclerosis; Benzoxazoles; Butyrates; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Hypertriglyceridemia; Male; Middle Aged; PPAR alpha; Proteins; Proteinuria; Renal Insufficiency; Treatment Outcome | 2020 |
Real-world Profile of a Selective Peroxisome Proliferator-activated Receptor α Modulator (SPPARMα) in Japanese Patients with Renal Impairment and Dyslipidemia.
Topics: Benzoxazoles; Butyrates; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; PPAR alpha; Renal Insufficiency | 2021 |